Evoclin Approval History
- FDA approved: Yes (First approved October 22nd, 2004)
- Brand name: Evoclin
- Generic name: clindamycin phosphate
- Dosage form: Foam
- Previous name: Actiza
- Company: Connetics Corporation
- Treatment for: Acne
Evoclin (clindamycin) is a topical antibiotic indicated for the treatment of acne vulgaris.
Development History and FDA Approval Process for Evoclin
|Oct 22, 2004||Evoclin Connetics Corporation - Treatment for Acne|
|Mar 4, 2004||Connetics' New Drug Application for Actiza Has Been Accepted For Filing by the FDA|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.